ResMed is trading higher today, showing modest gains as it tracks alongside a broader positive trend within the healthcare sector. The stock's performance follows a period of relative stagnation, where it posted a 2.7% loss over the last six months and lagged behind the S&P 500's 15.9% gain during the same timeframe. This upward movement aligns with strength in peer healthcare companies, including Medpace Holdings and Hims & Hers Health, which are also recording gains in today's session.